• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.60% Nasdaq Down0.39%

    Bio-Techne Corp. (TECH)

    83.38 Down 1.52(1.79%) Feb 11, 3:59PM EST
    ProfileGet Profile for:
    Bio-Techne Corp.
    614 McKinley Place NE
    Minneapolis, MN 55413
    United States - Map
    Phone: 612-379-8854
    Fax: 612-656-4400
    Website: http://www.techne-corp.com

    Index Membership:N/A
    Full Time Employees:1,356

    Business Summary 

    Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic products worldwide. The company operates through three segments: Biotechnology, Clinical Controls, and Protein Platforms. The Biotechnology segment provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal antibodies in goats, sheep, and rabbits, as well as monoclonal antibodies; microtiter-plate based kits under the Quantikine trade name, immunoassays based on encoded bead technology, and immunoassays based on planar spotted surfaces for researchers to quantify the level of a specific protein in biological fluids; and erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays for use as in vitro diagnostic devices. This segment also offers flow cytometry products, such as fluorochrome labeled antibodies and kits for use in determining the immuno-phenotypic properties of cells from various tissues; and natural or synthetic chemical compounds for use by investigators as agonists, antagonists, and/or inhibitors of various biological functions. The Clinical Controls segment provides a range of hematology controls and calibrators for impedance and laser type cell counters; and hematology control products for use as proficiency testing tools by laboratory certifying authorities. The Protein Platforms segment develops, manufactures, and sells tools comprising Simple Western platform, an assay for protein analysis and identification; SimplePlex platform, an assay used in research and clinical diagnostics; and Biologics Instrumentation to interrogate protein purity and identify contaminants during the development and production of biologics. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Bio-Techne Corp.

    Corporate Governance 
    Bio-Techne Corp.’s ISS Governance QuickScore as of Feb 1, 2016 is 1. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 1; Compensation: 4.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. Charles R. Kummeth , 56
    Chief Exec. Officer, Pres and Director
    Mr. James T. Hippel , 45
    Chief Financial Officer and VP of Fin.
    Ms. Brenda S. Furlow J.D., 56
    Sr. VP, Gen. Counsel and Sec.
    Mr. N. David Eansor , 55
    Sr. VP of Biotechnology
    Mr. Robert M. Gavin , 48
    Sr. VP of Protein Platforms Division
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders